南京麦澜德医疗科技股份有限公司 第二届监事会第十二次会议决议公告

Core Viewpoint - The company has approved the use of up to RMB 52,600 million of temporarily idle raised funds for cash management, ensuring that this does not affect the implementation of fundraising investment projects and is in the interest of all shareholders [3][22]. Group 1: Meeting Details - The second meeting of the supervisory board was convened on July 25, 2025, via communication, with all three supervisors present, complying with relevant laws and regulations [2]. - The meeting's resolutions were deemed legal and effective [2]. Group 2: Fund Management Proposal - The supervisory board approved the proposal to use up to RMB 52,600 million of temporarily idle raised funds for cash management, which aligns with regulatory requirements and does not conflict with the intended use of the raised funds [3][22]. - The funds will be invested in low-risk, high-liquidity products such as structured deposits, large certificates of deposit, and time deposits, with a usage period of 12 months from the approval date [7][11]. Group 3: Fundraising Overview - The company raised a total of RMB 100,725 million through its initial public offering, with a net amount of RMB 90,975.85 million after deducting issuance costs [7][8]. - All raised funds are stored in a dedicated account, and the company has established a three-party supervision agreement with the underwriter and the bank [8]. Group 4: Investment Purpose and Benefits - The purpose of using idle funds for cash management is to enhance fund utilization efficiency and increase returns while ensuring the safety of the raised funds [10]. - This strategy is expected to improve overall performance and provide better returns for shareholders [17]. Group 5: Approval and Oversight - The proposal received unanimous approval from the supervisory board, confirming that it complies with relevant regulations and does not harm shareholder interests [22][23]. - The underwriter has also expressed no objections to the cash management plan, affirming that it will not affect the company's main business operations [24].